コンポーネント:
治療オプション:
Militian Inessa Mesropovna 、薬局による医学的評価、 最終更新日:12.03.2022
アテンション! そのこのページの情報は医療専門家のみを対象としています! その情報が収集したオープン源を含めることが可能である重大な誤差! 注意して、このページ上のすべての情報を再確認してください!
同じ成分を持つトップ20の薬:
同じ治療法の上位20の薬:
For the relief of nasal congestion and congestion of mucous membranes of the upper respiratory tract associated with the common cold.
Oral
Adults and Children aged 12 years and over:
10 ml elixir every 4-6 hours up to 4 times a day.
Children 6 - 12 years
5 ml elixir every 4-6 hours up to 4 times a day. Not to be used for more than five days without the advice of a doctor. Parents or carers should seek medical attention if the child's condition deteriorates during treatment.
This product may be diluted 1:1 (1 in 2) or 1:3 (1 in 4) with syrup BP. These dilutions are stable for 4 weeks if stored at 25°C.
Children under 6 years
This product is contraindicated in children under the age of 6 years.
Use in the Elderly
There have been no specific studies of this product in the elderly, experience has indicated that normal adult dosage is appropriate.
Hepatic Dysfunction
Caution should be exercised when administering this product to patients with severe hepatic impairment.
Renal Dysfunction
Caution should be exercised when administering this product to patients with moderate to severe renal impairment.
Do not exceed the stated dose.
Keep out of the reach and sight of children.
This product is contraindicated in individuals with known hypersensitivity to the product or any of its components.
Concomitant use of other sympathomimetic decongestants, beta-blockers and monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOI treatment
Cardiovascular disease including hypertension
Diabetes mellitus
Phaeochromocytoma
Hyperthyroidism
Closed angle glaucoma
Severe renal impairment
Not to be used in children under the age of 6 years.
Use with caution in occlusive vascular disease
If any of the following occur, this product should be stopped
- Hallucinations
- Restlessness
- Sleep disturbances
Caution in moderate renal impairment
However, we will provide data for each active ingredient